249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions.
Direct and indirect remuneration (DIR) fees continue to rise at an alarming rate, inflating seniors’ out-of-pocket prescription drug costs and jeopardizing the viability of pharmacies and patient access.
Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing patient access.
As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care
NACDS: Congress must act to reduce patients’ out-of-pocket drug costs, preserve patients’ pharmacy access, and prevent unfair treatment of pharmacies
Expansive comments to CMS demonstrate that success of healthcare transformation relies on removing barriers to pharmacy care
